COMMUNIQUÉS West-GlobeNewswire

Noom Offers Oral Medications For Weight Loss Starting at $29
12/12/2024
A $29 entry price helps provide accessibility for people pursuing weight loss goals Service includes all features of Noom Med with asynchronous telehealth doctor visits, access to care coordinators, Noom Premium 1:1 [...]
Precede Biosciences Presents a Novel ER Transcriptional Dependency Index at SABCS 2024 Designed to Further Inform Use of Endocrine Therapy from a Simple Blood Test
12/12/2024
Precede Bio’s ER dependency index (PERDI) tests for both ER dependent and ER independent mechanisms of cancer growth, addressing an important unmet need in the field today There are approximately 130,000 people living [...]
BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder
12/12/2024
BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, [...]
Voting Rights and Shares Capital of the Company
11/12/2024
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Dec. 11, 2024 (GLOBE NEWSWIRE [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
11/12/2024
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 11 déc. 2024 (GLOBE NEWSWIRE) -- Paris, France, le 11 décembre 2024 Place de cotation [...]
MEDIROM Healthcare Technologies Inc. Announces Closing of Public Offering
11/12/2024
TOKYO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), “MEDIROM”, a holistic healthcare company that operates over 300 wellness salons across Japan and provides healthcare services [...]
Protara Announces Closing of $100 Million Public Offering
11/12/2024
NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the [...]
BriaCell Therapeutics Announces Proposed Public Offering
11/12/2024
PHILADELPHIA and VANCOUVER, British Columbia, Dec. 11, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that [...]
BrightSpring Health Services, Inc. Announced Refinancing of Term Loan B
11/12/2024
LOUISVILLE, Ky., Dec. 11, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex [...]
DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old
11/12/2024
Châtillon, France, December 11 th , 2024 DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old DBV and FDA aligned on key study design elements [...]
DBV confirme l’alignement avec la FDA (US) sur la procédure d'approbation accélérée du patch Viaskin® Peanut chez les enfants âgés de 1 à 3 ans
11/12/2024
Châtillon, France, le 11 décembre (22 :05 CEST) 2024 DBV confirme l’alignement avec la FDA (US) sur la procédure d'approbation accélérée du patch Viaskin® Peanut chez les enfants âgés de 1 à 3 ans DBV et la FDA se sont [...]
FemPulse Receives FDA IDE Approval for the Pivotal Clinical Trial of its Wearable Bioelectronic Device for Overactive Bladder in Women
11/12/2024
SAN FRANCISO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- FemPulse™ announced today Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin its EVANESCE II pivotal clinical trial [...]
SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting
11/12/2024
FORT LAUDERDALE, Fla., Dec. 11, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “ Company ” or “ SS Innovations ”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making [...]
Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports KDS2010 a Novel Oral Tablet Phase 2 Trial for Alzheimer’s Disease (AD) Currently Enrolling with U.S. Patient Cohort to be Added in 2025
11/12/2024
Currently enrolling randomized, double-blind, placebo-controlled, dose-finding, Phase 2 clinical trial to evaluate the safety and efficacy of KDS2010 in patients with Alzheimer’s disease with mild cognitive impairment [...]
CancerVax Targets Hard to Treat Pancreatic Cancer
11/12/2024
With limited options available to treat Pancreatic Ductal Adenocarcinoma (PDAC), the Company’s Universal Cancer Treatment Platform may provide hope for patients and doctors Lehi, UT, Dec. 11, 2024 (GLOBE NEWSWIRE) -- [...]
Dr. Steinbrech Unveils the Top 10 Most Requested Faces in Male Plastic Surgery for 2024
11/12/2024
World-renowned plastic surgeon, Dr. Steinbrech, today released his highly anticipated annual list of the most requested celebrity faces in male plastic surgery. This year's rankings offer a fascinating glimpse into the [...]
Bond by Solana Labs Partners with Baxus and Iridia to Debut Onchain Molecular Authentication Tech
11/12/2024
SAN FRANCISCO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Bond by Solana Labs , a web3 platform designed to elevate customer engagement for brands, is partnering with leading spirits marketplace Baxus and molecular identity [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 novembre 2024
11/12/2024
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 novembre 2024 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]
AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET
11/12/2024
PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY DECEMBER 16, 2024 FROM 5.30PM TO 6.30PM CET Paris, 11 December, 2024, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) will host a live webcast on Monday [...]

Pages